Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
11/20/2020 - 08:30 AM
SAN DIEGO , Nov. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, taking place virtually November 30 through December 3, 2020 .
In advance of the virtual conference and investor meetings, a pre-recorded fireside chat with Saundra Pelletier , CEO of Evofem Biosciences, will be made available on Monday, November 23 at 10:00 AM Eastern Time . Interested parties may access the fireside chat by visiting the
Investors section of the Evofem Biosciences website at www.evofem.com , under the Events and Presentations tab.
About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company's first commercial product, Phexxi® (lactic acid, citric acid and potassium bitartrate) , is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company is evaluating EVO100 in a Phase 3 clinical trial, 'EVOGUARD ,' for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. For more information, please visit www.evofem.com .
Phexxi® is a registered trademark of Evofem Biosciences, Inc.
Investor Relations Contact Amy Raskopf Evofem Biosciences, Inc.araskopf@evofem.com Mobile: (917) 673-5775
Media Contact Ellen Thomas Evofem Biosciences, Inc.ethomas@evofem.com Mobile: (718) 490-3248
View original content to download multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-piper-sandler-32nd-annual-virtual-healthcare-conference-301178010.html
SOURCE Evofem Biosciences, Inc.
EVFM Rankings
N/A Ranked by Stock Gains
EVFM Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
San Diego
About EVFM
evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.